Guideline for radiotherapy with curative intent in patients with early-stage medically inoperable non-small-cell lung cancer

被引:22
作者
Falkson, C. B. [1 ,2 ]
Vella, E. T. [3 ]
Yu, E. [4 ,5 ]
El-Mallah, M. [6 ]
Mackenzie, R. [3 ]
Ellis, P. M. [7 ,8 ]
Ung, Y. C. [9 ]
机构
[1] Kingston Gen Hosp, Canc Ctr Southeastern Ontario, Radiat Oncol, Kingston, ON, Canada
[2] Queens Univ, Kingston, ON, Canada
[3] McMaster Univ, Program Evidence Based Care, Canc Care Ontario, Hamilton, ON, Canada
[4] London Reg Canc Ctr, Radiat Oncol, London, ON, Canada
[5] Western Univ, London, ON, Canada
[6] Durham Reg Canc Ctr, Radiat Oncol, Oshawa, ON, Canada
[7] McMaster Univ, Med Oncol, Juravinski Canc Ctr, Hamilton, ON, Canada
[8] McMaster Univ, Dept Oncol, Hamilton, ON, Canada
[9] Sunnybrook Odette Canc Ctr, Radiat Oncol, Toronto, ON, Canada
关键词
Early-stage disease; inoperable tumours; non-small-cell lung cancer; stereotactic body radiation therapy; stereotactic ablative radiation therapy; clinical practice guidelines; STEREOTACTIC-BODY-RADIOTHERAPY; STANDARDIZED UPTAKE VALUE; RADIATION-THERAPY; IMPROVED SURVIVAL; DEVELOPMENT CYCLE; OUTCOMES; TOXICITY; EFFICACY;
D O I
10.3747/co.24.3358
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives For this guideline, we investigated the effectiveness of radiotherapy with curative intent in medically inoperable patients with early-stage non-small-cell lung cancer (NSCLC). Methods The guideline was developed by Cancer Care Ontario's Program in Evidence-Based Care and by the Lung Cancer Disease Site Group through a systematic review of mainly retrospective studies, expert consensus, and formal internal and external reviews. Recommendations Stereotactic body radiation therapy (SBRT) with curative intent is an option that should be considered for patients with early-stage, node-negative, medically inoperable NSCLC. Qualifying Statements Because of the high dose per fraction, the planning process and treatment delivery for SBRT require the use of advanced technology to maintain an appropriate level of safety. Consistent patient positioning and 4-dimensional analysis of tumour and critical structure motion during simulation and treatment delivery are essential. Preliminary results for proton-beam therapy have been promising, but the technique requires further clinical study. Recommended fractionation schemes for SBRT should result in a biologically effective dose of 100 or greater by the linear quadric model, choosing an alpha/beta value of 10 [BED10(LQ)>= 100]. Qualifying Statements Because of the increased risk of treatment-related adverse events associated with centrally located tumours, consideration of tumour size and proximity to critical central structures is required when determining the dose and fractionation. Examples of dose-fractionation schemes used in the included studies have been provided. Based on the current evidence and the opinion of the authors, radiation doses at BED10(LQ) greater than 146 might significantly increase toxicity and should be avoided. Determination of the radiation BED by the linear quadratic model has limitations for the extreme hypofractionated schemes used in SBRT.
引用
收藏
页码:E44 / E49
页数:6
相关论文
共 34 条
[1]  
[Anonymous], CLIN LUNG CANC
[2]   Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy [J].
Borst, Gerben R. ;
Ishikawa, Masayori ;
Nijkamp, Jasper ;
Hauptmann, Michael ;
Shirato, Hiroki ;
Onimaru, Rikiya ;
van den Heuvel, Michel M. ;
Belderbos, Jose ;
Lebesque, Joos V. ;
Sonke, Jan-Jakob .
RADIOTHERAPY AND ONCOLOGY, 2009, 91 (03) :307-313
[3]   Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: The role of practitioner feedback [J].
Browman, GP ;
Newman, TE ;
Mohide, EA ;
Graham, ID ;
Levine, MN ;
Pritchard, KI ;
Evans, WK ;
Maroun, JA ;
Hodson, DI ;
Carey, MS ;
Cowan, DH .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) :1226-1231
[4]   THE PRACTICE GUIDELINES DEVELOPMENT CYCLE - A CONCEPTUAL TOOL FOR PRACTICE GUIDELINES DEVELOPMENT AND IMPLEMENTATION [J].
BROWMAN, GP ;
LEVINE, MN ;
MOHIDE, EA ;
HAYWARD, RSA ;
PRITCHARD, KI ;
GAFNI, A ;
LAUPACIS, A .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (02) :502-512
[5]  
Cancer Care Ontario (cco), PAT PATHW IS IT LUNG
[6]   What Would Be the Most Appropriate α/β Ratio in the Setting of Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer [J].
Chi, Alexander ;
Wen, Sijin ;
Liao, Zhongxing ;
Fowler, Jack ;
Xu, Jiahong ;
Nguyen, Nam P. ;
Welsh, James S. ;
Komaki, Ritsuko .
BIOMED RESEARCH INTERNATIONAL, 2013, 2013
[7]   Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry [J].
Davis, Joanne N. ;
Medbery, Clinton, III ;
Sharma, Sanjeev ;
Perry, David ;
Pablo, John ;
D'Ambrosio, David J. ;
McKellar, Heidi ;
Kimsey, Frank C. ;
Chomiak, Paul N. ;
Mahadevan, Anand .
JOURNAL OF RADIATION ONCOLOGY, 2015, 4 (01) :55-63
[8]   Medically inoperable lung carcinoma: The role of radiation therapy [J].
Dosoretz, DE ;
Katin, MJ ;
Blitzer, PH ;
Rubenstein, JH ;
Galmarini, DH ;
Garton, GR ;
Salenius, SA .
SEMINARS IN RADIATION ONCOLOGY, 1996, 6 (02) :98-104
[9]   Stereotactic body radiation therapy for stage I non-small cell lung cancer: a small academic hospital experience [J].
Factor, Oren B. ;
Vu, Charles C. ;
Schneider, Jeffrey G. ;
Witten, Matthew R. ;
Schubach, Scott L. ;
Gittleman, Alicia E. ;
Catell, Donna T. ;
Haas, Jonathan A. .
FRONTIERS IN ONCOLOGY, 2014, 4
[10]   A Collaborative Analysis of Stereotactic Lung Radiotherapy Outcomes for Early-Stage Non-Small-Cell Lung Cancer Using Daily Online Cone-Beam Computed Tomography Image-Guided Radiotherapy [J].
Grills, Inga Siiner ;
Hope, Andrew J. ;
Guckenberger, Matthias ;
Kestin, Larry L. ;
Werner-Wasik, Maria ;
Yan, Di ;
Sonke, Jan-Jakob ;
Bissonnette, Jean-Pierre ;
Wilbert, Juergen ;
Xiao, Ying ;
Belderbos, Jose .
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) :1382-1393